Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 20 min 22 sec ago

HIV and cancer teams double up to seek out new disease killers

3 hours 42 min ago
LONDON, (Reuters) - HIV experts at an international conference starting on Saturday are keenly courting colleagues in oncology to explore whether advances in harnessing the immune system against cancer can help the search for a cure for AIDS.

U.S. abortion support groups put on more public face

5 hours 33 min ago
LOUISVILLE, Kentucky (Reuters) - Patricia Canon drives poor rural Kentucky women to distant abortion clinics each week, part of a national army of volunteers who are growing bolder even as abortion foes ratchet up opposition to the activists they have branded as "accomplices to murder."

UK's Boots 'truly sorry' over morning-after pill campaign response

8 hours 34 min ago
LONDON (Reuters) - British pharmacy chain Boots has apologized for its response to a campaign calling for it to cut the price of one of its morning-after pills and said it was looking for cheaper alternatives.

Roche's Tecentriq receives positive opinion from EU medicines agency

9 hours 28 min ago
ZURICH (Reuters) - A European Medicines Agency (EMA) panel said on Friday it has recommended Roche's immunotherapy Tecentriq as a treatment for advanced bladder and lung cancer, setting the stage for European Commission approval this year.

Senate rule deals setback to Republican healthcare bill

15 hours 51 min ago
(Reuters) - Republicans in the U.S. Senate were dealt another blow in their effort to repeal Obamacare on Friday when the keeper of the Senate's rules said certain provisions in their healthcare bill, such as defunding Planned Parenthood, could not be included.

Lesser-known gene mutations may boost breast cancer risk in Jewish women

19 hours 4 min ago
(Reuters Health) - Jewish women of European descent may be at risk for additional genetic mutations that increase their risk of breast cancer, according to a new study.

U.S. CDC says salmonella outbreak linked to papayas sickens 47

19 hours 19 min ago
(Reuters) - An outbreak of salmonella food poisoning linked to a type of papaya has sickened 47 people from 12 states, including one person in New York City who died and 12 who were hospitalized, U.S. health officials said on Friday.

Heart attack patients missing out on smoking cessation drugs

20 hours 26 min ago
(Reuters Health) - People may be inspired to quit smoking cigarettes soon after a heart attack, but new research suggests many don't take advantage of drugs that help kick the habit.

Want better muscles? More protein may help . . . up to a point

20 hours 31 min ago
(Reuters Health) - People who regularly do resistance exercises may get stronger and build more lean muscle mass when they add more protein to their diet, a recent study suggests.

U.S. jury sides with Amphastar over Momenta in drug patent trial

21 hours 34 min ago
BOSTON (Reuters) - A federal jury handed Amphastar Pharmaceuticals Inc a big win on Friday after it was accused of infringing on a patent held by Momenta Pharmaceuticals Inc through its production of a generic version of the blood-thinner Lovenox.

India to quiz Philip Morris on marketing of Marlboro

22 hours 8 min ago
NEW DELHI (Reuters) - India plans to seek an explanation from Philip Morris International Inc about its marketing practices after Reuters reported that the tobacco giant used tactics that government officials say flout the country's law, a health ministry official said on Friday.

High blood pressure in pregnancy may return before middle age

July 21, 2017 - 11:14pm
(Reuters Health) - High blood pressure during pregnancy has long been linked to greater odds of redeveloping the condition in middle age, but a new study suggests that the increased risk may exist soon after delivery and persist for decades.

Bayer says asbestos-related tumor treatment misses key goal

July 21, 2017 - 10:29pm
FRANKFURT (Reuters) - Germany's Bayer said on Friday a cancer treatment for patients with a type of tumor often caused by asbestos had failed to meet its main goal in a clinical trial.

Indian musician plays guitar as doctors perform brain surgery

July 21, 2017 - 7:59pm
(Reuters) - Musician Abhishek Prasad strummed his guitar throughout his neurosurgery to help doctors zero in on the part of the brain being operated on during the first such procedure in India.

WHO sees high risk from Kenya cholera outbreak

July 21, 2017 - 6:03pm
GENEVA (Reuters) - An outbreak of cholera in Kenya poses a high risk to the region and a moderate threat globally, the World Health Organization said on Friday, after delegates at two international conferences were hit.

Yemen cholera to spread with rains; Oxfam sees 600,000 cases

July 21, 2017 - 5:57pm
GENEVA (Reuters) - Yemen's cholera outbreak is far from being controlled and may be further exacerbated by the rainy season, even if the rate of new cases appears to be slowing in some hotspots, the World Health Organisation said on Friday.

EMA panel recommends against Nektar, Daiichi Sankyo's breast cancer drug

July 21, 2017 - 5:25pm
(Reuters) - European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit.

Janssen-Cilag's HIV drug gets EU regulatory panel's nod

July 21, 2017 - 5:16pm
(Reuters) - A European regulatory panel recommended granting approval to a treatment for HIV infection developed by Janssen-Cilag International, a unit of U.S. drugmaker Johnson & Johnson.

Europe backs nuclear medicine for cancer that killed Steve Jobs

July 21, 2017 - 5:11pm
LONDON (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.

Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval

July 21, 2017 - 5:06pm
(Reuters) - European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer called Merkel cell carcinoma.